Abdulhalim S Serafi

Prof. Dr. Abdulhalim S Serafi


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
SAShalan Alaamri
Shalan Alaamri
ASAbdulhalim S Serafi
Abdulhalim S Serafi
ZHZahir Hussain
Zahir Hussain
MAMunira M. Alrooqi
Munira M. Alrooqi
MBMohammed A. Bafail
Mohammed A. Bafail
SSSumera Sohail
Sumera Sohail
The precise association of serum leptin (Lep) with the body mass index (BMI) and blood pressure (BP) is not well known for understanding their involvement in health and disease. Hence, the present study was conducted to investigate the association of BP, BMI and serum Lep levels in young normal-weight (NW) and overweight (OW) male Saudi students. The NW (n: 198) and OW (n: 192) male subjects in the age range of 18–20 years were consulted. The BP was measured with a mercury sphygmomanometer. Leptin Human ELISA Kits were employed for the determination of the serum Lep levels. The mean ± SD values of BMI (kg/m2), Lep (ng/mL), systolic BP (SBP; mmHg), and diastolic BP (DBP; mmHg) all showed significant differences for young OW vs. NW subjects as: 27.52 ± 1.42 vs. 21.49 ± 2.03; 10.70 ± 4.67 vs. 4.68 ± 1.91; 121.37 ± 2.59 vs. 118.51 ± 1.54 and 81.44 ± 1.97 vs. 78.79 ± 1.44, respectively. All associations (among BMI, Lep, SBP and DBP) showed a positive linear and significant correlation, except the nonsignificant correlation of BMI and SBP for the NW group. Other variables showing significant variation for NW vs. OW subjects were: interleukin-6, high sensitivity C-reactive protein, apelin (APLN) and resistin. Serum APLN correlated significantly with Lep, BMI, SBP and DBP in lower and higher levels of BMI, with considerable progressive patterns in both the NW and OW groups and subgroups. The present study in young Saudi male students presents significant variations for BP and serum leptin levels, and a significant positive linear association among serum leptin, BMI and BP.

2 February 2025 in Pathophysiology
Verified
Journal Article
Open access
PDF file
SAShalan Alaamri
Shalan Alaamri
ASAbdulhalim S Serafi
Abdulhalim S Serafi
ZHZahir Hussain
Zahir Hussain
SBShouq K. Bafail
Shouq K. Bafail
MBMohammed A. Bafail
Mohammed A. Bafail
SSSumera Sohail
Sumera Sohail
Background/Objectives: One of the major causes of hypertension (HT) is the transition of normal weight (NW) status to overweight (OW) status and obesity in a population, which leads to cardiovascular disease (CVD) and other disorders. A variety of factors/variables are involved in the development of HT and OW-related hypertension (OHT). However, we planned to investigate the pathophysiological role of serum leptin (Lep), tumor necrosis factor-alpha (TNF-α), interleukin-6 (IL-6), total cholesterol (TC) and serum testosterone (ST) in OHT in middle-aged men. Methods: We consulted three groups of middle-aged men (age: 51–60 years)—an HT group (n: 97, high normal weight (HNW), body mass index (BMI): 23–24.9 kg/m2); an OHT group (n: 97, high overweight (HOW), BMI: 28–29.9 kg/m2) and a normal control group (NC, n: 98, HNW)—to investigate the variations in and correlations of Lep, IL-6, TNF-α, ST, TC and other variables. Results: Significant variations were obtained for the comparisons of TNF-α, Lep, ST and TC for the patient groups. OHT vs. NC showed a significant difference for ST. OHT vs. NC and OHT vs. HT had significant variations for IL-6. Significant changes were obtained for the serum levels of TNF-α, Lep, IL-6, ST and TC among groups. Significant and positive linear associations were obtained for TNF-α, Lep, TC and IL-6. Significant and negative linear associations were found for ST plotted against Lep, TNF-α and IL-6. Conclusions: The current report provides pathophysiological evidence of the interactive role of serum Lep, TNF-α, ST, TC and IL-6 in middle-aged men with HT and OHT. We suggest that the changes we noted in the present study would be helpful for further BMI-based studies in various subcategories of NW, OW and obese subjects with/without HT.

1 January 2024 in Open Chemistry
Verified
Journal Article
Open access
PDF file
ASAbdulhalim S Serafi
Abdulhalim S Serafi
MAMuhammad Ahmed
Muhammad Ahmed
Imran ShahidImran Shahid
Imran Shahid
AAAisha Azmat
Aisha Azmat
ABAmmar Bader
Ammar Bader
RARizwan Ahmad
Rizwan Ahmad
Aloe species are known for the treatment of various conditions including diabetes mellitus, hypocholesteremia, and glycation end products. Nevertheless, the biological activity of Aloe armatissima is yet to be reported. It is a first-time report to evaluate the Aloe armatissima leaves (AAL) extract for its antioxidant, anti-glycation, anti-hyperglycemic, and anti-hyperlipidemic potential. In vitro tests of 1,1-diphenyl-2-picrylhydrazyl for the antioxidant and HSA for the antiglycation activity whereas in vivo models were used to assess the toxicity, antihyperglycemic, and anti-hypercholesteremic effects. The volatile profile was determined via gas chromatography-mass spectrometry. The IC50 values of 116 ± 0.66 (μg/mL) for antioxidant activity and 0.21 ± 0.009 (mg/mL) for antiglycation activity were observed for the AAL extract. The acute toxicity in the animal model revealed a lack of toxicity for the extract. The in vivo models exhibited a dose-dependent hypoglycemic and anti-hyperglycemic effects with significant (P < 0.01) blood glucose levels reduction. Moreover, a profound decrease in serum cholesterol, triglyceride, and LDL along with a significant (P < 0.05) increase in HDL and serum insulin levels was recorded. The statistical analysis demonstrated the values of F (24,125) = 23.95, P = 0.001, effect size = 1.95 (normoglycemic mice), F (24,125) = 143.21, P = 0.001, effect size = 4.79 (glucose loaded mice), and F (24,125) = 82.69, P = 0.001, effect size = 3.6 (diabetic model). GCMS showed the presence of eleven compounds with tetratetracontane (100%), β-sitosterol (27.76), and vitamin E (18.68) in major amounts. The results underscore the extract’s capacity to effectively combat various ailments; however, the active phytochemicals need to be isolated and the pharmacological activities may be established at the molecular level.

1 January 2025 in Journal of Clinical Medicine Research
Verified
Journal Article
Open access
PDF file
DQDina Qahwaji
Dina Qahwaji
ASAbdulhalim S Serafi
Abdulhalim S Serafi
SAShalan Alaamri
Shalan Alaamri
ZHZahir Hussain
Zahir Hussain
MBMohammed A. Bafail
Mohammed A. Bafail
SSSumera Sohail
Sumera Sohail
Background: Association of serum vitamin D (vitD) with leptin (Lep) and tumor necrosis factor-alpha (TNF-α) is not precisely known in overweight hypertensive (OW-HT) postmenopausal (PMP) women. Hence, the present study was carried out to investigate the body mass index (BMI)-based correlation of serum vitD with Lep and TNF-α in OW-HT PMP women. Methods: Women subjects in their early PMP (n = 346, age: 51 - 60 years) categorized into three groups had main inclusion criteria of specified range of age, BMI and blood pressure (BP). Enzyme-linked immunosorbent assay (ELISA) and other kit methods were employed to investigate the role of various variables in three subject groups (normal weight normotensive (NW-NT, n = 116, BMI (kg/m2): 22 - 24.9), normal weight hypertensive (NW-HT, n = 115, BMI: 22 - 24.9) and OW-HT (n = 115, BMI: 25 - 29.9) PMP women). Results: A significant negative linear correlation of vitD with serum Lep and TNF-α, and a significant positive linear correlation of BMI with Lep and TNF-α in OW-HT PMP women were obtained. Significantly higher levels of serum Lep, TNF-α and interleukin-6 (IL-6) were found in OW-HT PMP women, as compared to NW-HT PMP women. Conclusions: The present study suggests that decreased serum vitD levels correlate with the Lep and TNF-α in OW-HT PMP women. However, further studies may help understand the impact of vitD in cardiovascular events and the influencing factors in OW-HT PMP women.

21 June 2023 in Preprints.org
Verified
Preprint
Open access
PDF file
SAShalan Alaamri
Shalan Alaamri
ASAbdulhalim S Serafi
Abdulhalim S Serafi
ZHZahir Hussain
Zahir Hussain
SBShouq K. Bafail
Shouq K. Bafail
MBMohammed A. Bafail
Mohammed A. Bafail
SSSumera Sohail
Sumera Sohail
Hypertension (HT) is a very common risk factor and a frequent cause of morbidity and mortality worldwide mainly due to much increase in overweight (OW) and obesity that manifests in various forms of cardiovascular disease (CVD). There are a number of factors that may cause overweight hypertension (OHT). However, we planned to conduct the present work to study the HT and OHT men for finding the variation, interrelationship and association of important cytokines mainly serum leptin (Lep) and tumor necrosis factor-alpha (TNF-α), serum testosterone (ST), total cholesterol (TC) and inflammatory status by measuring interleukin-6 (IL-6). Three groups of subjects, the normal controls (NC; n:98; age range: 51-60 years), HT (n: 97; age range: 51-60 years) subjects, and OHT (n: 97; age range: 51-60 years) subjects were studied. Comparisons for Lep, ST, TNF-α, IL-6 and TC levels for the subject groups showed significant variations. The ST indicated significant difference only for NC vs. OHT. The IL-6 gave significant difference for NC vs. OHT and HT vs. OHT. The one-way ANOVA showed significant difference among groups for BMI, TC, IL-6, TNF-α, ST and Lep levels. Significant positive linear correlation for all groups among Lep, TNF-α, IL-6 and TC were found. The ST against TC for HT and OHT groups presented non-significant negative linear correlations. The ST showed significant negative linear correlation with other variables. Conclusively, the present study uncovers the interactive impact of serum leptin, TNF-α, testosterone, total cholesterol and IL-6 in hypertensive and overweight-related hypertensive men.

8 February 2024 in Research Square
Verified
Preprint
Open access
PDF file
ASAbdulhalim S Serafi
Abdulhalim S Serafi
MAMuhammad Ahmed
Muhammad Ahmed
ISImran Shahid
Imran Shahid
AAAisha Azmat
Aisha Azmat
ABAmmar Badar
Ammar Badar
RARizwan Ahmad
Rizwan Ahmad
Background: Aloe species are known for the treatment of various conditions including diabetes mellitus (DM), hypercholesteremia, and glycation end products. Nevertheless, the biological activity of Aloe armatissima is yet to be reported. It’s a first-time report to evaluate the Aloe armatissima leaves (AAL) extract for its antioxidant, anti-glycation, anti-hyperglycemic, and anti-hyperlipidemic potential. Methodology: in vitro tests of DPPH for the antioxidant and HSA for the antiglycation activity whereas, in vivo models were used to assess the toxicity, antihyperglycemic, and ani-hypercholesteremic effects. The volatile profile was determined via GC-MS. Results: the IC50 values of 116±0.66 (mg/mL) for antioxidant activity and 0.21±0.009 (mg/mL) for antiglycation activity were observed for the AAL extract. The acute toxicity in animal model revealed a lack of toxicity for the extract. The in vivo models exhibited a dose dependent hypoglycemic and anti-hyperglycemic effects with significant (P<0.01) BGLs reduction. Moreover, a profound decrease in serum cholesterol, triglyceride, and LDL along with a significant (P<0.05) increase in HDL and serum insulin levels were recorded. The statistical analysis demonstrated the values of F(24,125)=23.95, P=0.001, effect size=1.95 (normoglycemic mice), F(24,125)=143.21, P=0.001, effect size=4.79 (glucose loaded mice), and F(24,125)=82.69, P=0.001, effect size=3.6 (diabetic model). GCMS showed the presence of eleven compounds with Tetratetracontane (100%), β-Sitosterol (27.76), and vitamin-E (18.68) in major amounts. Conclusion: the results underscore the extract’s capacity to effectively combat various ailments however, the active phytochemicals need to be isolated and the pharmacological activities may be established at molecular level.